Brief: Pacira Biosciences Q1 Adjusted EBITDA USD 44.6 Million Vs. IBES Estimate USD 45.3 Million
07/05/2024 21:00
May 07 (Reuters) - Pacira Biosciences Q1 adjusted net income USD 31.1 million vs. IBES estimate USD 30.7 million. * Q1 cash & investments USD 325.9 million * Q1 net income USD 9 million * Q1 revenue USD 167.1 million vs. IBES estimate USD 165.4 million
Recent news on Pacira BioSciences
See all newsUS STOCKS ON THE MOVE-Palantir, Haemonetics
U.S. STOCKS ON THE MOVE-Palantir, Haemonetics, Starbucks
Pacira BioSciences jumps on $1.65 billion Viatris buyout deal
Brief: Viatris - Pacira To Pay Viatris $62 Million Termination Fee Under Specified Circumstances
Pacira BioSciences jumps on $1.65 billion Viatris buyout deal